Skip to main navigation

Urogen - Corp Menu Left

Home

About UroGen

Leadership
Collaborations

Products

Pipeline

Low-grade NMIBC
High-grade NMIBC
OAB

Technical innovation

Urogen - Corp Menu Right

Investors

News Releases
Events & presentations
Financials
Governance
Stock information
Annual Report & Proxy
Resources

Contact

Careers
Funding requests

Privacy policy | Terms of use

Explore

Investors

UroGen Pharma

UroGen Pharma

Investors

Urogen - Investor Relations

Overview

News Releases

Events & Presentations

Financials

Governance

Stock Information

Annual Report & Proxy

Resources

News Releases

News Releases

Year

Feb 25, 2020

UroGen Pharma Announces March 2020 Investor Conference Schedule

NEW YORK --(BUSINESS WIRE)--Feb. 25, 2020-- UroGen Pharma Ltd. (Nasdaq:URGN) a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options, today announced that it will participate in fireside chats at

Read More

Feb 24, 2020

UroGen Pharma to Report Fourth Quarter and Full Year 2019 Financial Results on Monday, March 2, 2020

Conference Call and Webcast Scheduled for Monday, March 2, 2020 at 8:30 AM ET NEW YORK --(BUSINESS WIRE)--Feb. 24, 2020-- UroGen Pharma Ltd. (Nasdaq:URGN), a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve

Read More

Jan 08, 2020

UroGen to Present at 38th Annual J.P. Morgan Healthcare Conference

NEW YORK --(BUSINESS WIRE)--Jan. 8, 2020-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options, today announced that Liz Barrett , President and Chief

Read More

Pagination

First page
Previous page
Page 1
Current page 2

Urogen - Tools

Print Page
Email Alerts
RSS Feeds

Follow us on

Privacy Policy
Terms of Use

© UroGen Pharma, Inc. All rights reserved.